Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Pk Med SAS is active in the Biotechnology & Pharmaceuticals technology area. The company's patent portfolio currently includes 1 pending office action. This prosecution activity is limited to 1 distinct examiner and 1 distinct art unit. The presence of 1 distinct art unit suggests that the company's current filings are highly specialized within the biotech sector. This narrow focus can streamline the examination process by keeping the review within a single technical group at the patent office.
The busiest examiner identified is SAEED, ALI S, who is overseeing 1 busiest examiner pending office action. This examiner handles the 1 pending office action that makes up the company's current workload. For a practitioner, this means that the prosecution success is tied directly to the feedback from SAEED, ALI S. The fact that there is 1 pending office action indicates a period of targeted patent activity. Effective prosecution requires a deep understanding of the specific examiner's technical perspective and prior rulings on similar pharmaceutical matters.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SAEED, ALI S | 1 | 31.6% | +33.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16634136 | DRUG DELIVERY COMPOSITION | SAEED, ALI S | — |
| Art Unit | Apps |
|---|---|
| 1616 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 16634136 | DRUG DELIVERY COMPOSITION | SAEED, ALI S | 1616 | §103 | Non-Final OA | — | Pending | Jan 25, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPk Med SAS has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Ali S Saeed has the most, with 1 of Pk Med SAS's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
